Regeneron
The Latest
-
COVID-19 Vaccine Alternative? Regeneron CEO Says Its Antibody Cocktail Gives Protection For Up To Eight Months
The new drug adds to the list of growing COVID-19 treatments that show promise. 
The new drug adds to the list of growing COVID-19 treatments that show promise. -
Eli Lilly COVID Vaccine Test Halted On Safety Issues
Lilly research director Mathai Mammen said it was a "temporary pause" that may not have any connections to their vaccine. 
Lilly research director Mathai Mammen said it was a "temporary pause" that may not have any connections to their vaccine. -
Why Donald Trump Calls His COVID-19 Diagnosis A 'Blessing From God'
Donald Trump posted a five-minute video on social media, wherein he refers to his diagnosis as a "blessing in disguise." 
Donald Trump posted a five-minute video on social media, wherein he refers to his diagnosis as a "blessing in disguise." -
Trump Also Given Experimental Drug Remdesivir To Help Shorten His Illness From COVID
Remdesivir costs around $520 per shot, based on the price announced by its developer, Gilead Sciences in June. 
Remdesivir costs around $520 per shot, based on the price announced by its developer, Gilead Sciences in June. -
Sanofi, Regeneron Say Experimental Drug Is Useless Against COVID-19
More than 25 percent of patients given Kevzara shots experienced severe adverse events. 
More than 25 percent of patients given Kevzara shots experienced severe adverse events. -
Regeneron COVID-19 Treatment Enters Final-Stage Trials
The tests, in tandem with the US National Institute of Allergy and Infectious Diseases, is expected to enroll 2,000 subjects. 
The tests, in tandem with the US National Institute of Allergy and Infectious Diseases, is expected to enroll 2,000 subjects.
